Cargando…
Severe COVID-19: NLRP3 Inflammasome Dysregulated
SARS-CoV-2 might directly activate NLRP3 inflammasome resulting in an endogenous adjuvant activity necessary to mount a proper adaptive immune response against the virus. Heterogeneous response of COVID-19 patients could be attributed to differences in not being able to properly downregulate NLRP3 i...
Autores principales: | van den Berg, Daan F., te Velde, Anje A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7332883/ https://www.ncbi.nlm.nih.gov/pubmed/32670297 http://dx.doi.org/10.3389/fimmu.2020.01580 |
Ejemplares similares
-
Targeting the NLRP3 Inflammasome in Severe COVID-19
por: Freeman, Tracey L., et al.
Publicado: (2020) -
Role of NLRP3 inflammasome in diabetes and COVID-19 role of NLRP3 inflammasome in the pathogenesis and treatment of COVID-19 and diabetes NLRP3 inflammasome in diabetes and COVID-19 intervention
por: Zhang, Jiayu, et al.
Publicado: (2023) -
NLRP3 Inflammasome: The Stormy Link Between Obesity and COVID-19
por: López-Reyes, Alberto, et al.
Publicado: (2020) -
Overnutrition-induced gout: An immune response to NLRP3 inflammasome dysregulation by XOD activity increased in quail
por: Wu, Hao, et al.
Publicado: (2022) -
Regulation of NLRP3 Inflammasome by Phosphorylation
por: Song, Nan, et al.
Publicado: (2018)